A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin
Open Access
- 15 April 2001
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 84 (8) , 1029-1035
- https://doi.org/10.1054/bjoc.2001.1723
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Regional differences in HIV testing among European patients with sexually transmitted diseases: trends in the history of HIV testing and knowledge of current serostatusAIDS, 2000
- Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomesInternational Journal of Cancer, 1992
- Cisplatin-lnduced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensityCancer, 1992
- Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.Proceedings of the National Academy of Sciences, 1991
- A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin.Journal of Clinical Oncology, 1990
- A pharmacokinetic study of high-dose continuous infusion cisplatin in children with solid tumors.Journal of Clinical Oncology, 1989
- Continuous infusion of high-dose cisplatin in children: Pharmacokinetics of free and total platinumEuropean Journal of Cancer and Clinical Oncology, 1987
- Ototoxicity of cis-diamminedichloroplatinum (II): Influence of dose, schedule and mode of administrationEuropean Journal of Cancer and Clinical Oncology, 1983
- PHARMACOKINETIC EVALUATION OF CISPLATIN IN CHILDREN WITH MALIGNANT SOLID TUMORS - A PHASE-II STUDY1981
- Distribution of cis-platin in bloodChemico-Biological Interactions, 1978